Literature DB >> 1740285

Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicators.

L M Pereira1, P G Langley, K M Hayllar, J M Tredger, R Williams.   

Abstract

The value of coagulation factor V and VIII/V levels as prognostic indicators was assessed in 27 patients with fulminant hepatic failure and compared with other predictive indices. Admission factor V levels were significantly reduced in 22 patients with paracetamol induced hepatic failure compared with a healthy control group (median 9.5% v 103%, respectively; p less than 0.001) and with lower values in non-A non-B hepatitis (median 2.7%). Values in the seven patients who died after paracetamol overdose, considered together with the four who underwent liver transplantation (group median 5.1%), were significantly lower than in the 11 who survived (median 11.8%; p less than 0.01). Median admission factor VIII was higher in those who died or received a transplant than in those who survived (298% v 162%; p less than 0.05), with both results higher than in healthy volunteers (median 104%; p less than 0.01) but lower than in non-A non-B hepatitis (median 340%). The ratio of factor VIII/V on admission was less than 30 in all patients who survived paracetamol overdose (median 17) with corresponding values greater than 30 in 10 of 11 of those who died (median 39). A factor V result less than or equal to 10% on admission predicted an adverse outcome in 10 of 11 fatal cases, a 91% sensitivity which was greater than for the previously defined indicator of an arterial blood pH less than 7.30 on admission (sensitivity 82%). Prothrombin time at admission or on day 4 did not usefully predict outcome in our series. Predictive accuracy was 73% and 82% for factor V and admission acidosis respectively and 95% for factor V in conjunction with admission coma grade III or IV and factor VIII (ratio > 30). These criteria may be useful in selecting patients with paracetamol induced fulminant hepatic failure for transplantation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1740285      PMCID: PMC1373872          DOI: 10.1136/gut.33.1.98

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  17 in total

1.  Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine.

Authors:  P M Harrison; R Keays; G P Bray; G J Alexander; R Williams
Journal:  Lancet       Date:  1990-06-30       Impact factor: 79.321

2.  Assessment of prognosis in fulminant hepatic failure.

Authors:  N Tygstrup; L Ranek
Journal:  Semin Liver Dis       Date:  1986-05       Impact factor: 6.115

Review 3.  Protective agents for acetaminophen overdose.

Authors:  M Davis
Journal:  Semin Liver Dis       Date:  1986-05       Impact factor: 6.115

4.  Orthotopic liver transplantation for acute and subacute hepatic failure in adults.

Authors:  R R Peleman; J S Gavaler; D H Van Thiel; C Esquivel; R Gordon; S Iwatsuki; T E Starzl
Journal:  Hepatology       Date:  1987 May-Jun       Impact factor: 17.425

5.  Increased factor VIII complex in fulminant hepatic failure.

Authors:  P G Langley; R D Hughes; R Williams
Journal:  Thromb Haemost       Date:  1985-10-30       Impact factor: 5.249

6.  Low antithrombin III in acute hepatic failure at term.

Authors:  J Mosvold; U Abildgaard; H Jenssen; R Andersen
Journal:  Scand J Haematol       Date:  1982-07

7.  Multivariate analysis of prognostic factors in fulminant hepatitis B.

Authors:  J Bernuau; A Goudeau; T Poynard; F Dubois; G Lesage; B Yvonnet; C Degott; A Bezeaud; B Rueff; J P Benhamou
Journal:  Hepatology       Date:  1986 Jul-Aug       Impact factor: 17.425

8.  Clinical and prognostic differences in fulminant hepatitis type A, B and non-A non-B.

Authors:  A E Gimson; Y S White; A L Eddleston; R Williams
Journal:  Gut       Date:  1983-12       Impact factor: 23.059

9.  Antihaemophilic factor A activity, F VIII-related antigen and von Wilebrand factor in hepatic cirrhosis.

Authors:  G Baele; E Matthijs; F Barbier
Journal:  Acta Haematol       Date:  1977       Impact factor: 2.195

10.  The effect of liver disease on factors V, VIII and protein C.

Authors:  D A Kelly; F J O'Brien; R A Hutton; E G Tuddenham; J A Summerfield; S Sherlock
Journal:  Br J Haematol       Date:  1985-11       Impact factor: 6.998

View more
  13 in total

1.  Low serum factor V level: early predictor of allograft failure and death following liver transplantation.

Authors:  Mauricio C Zulian; Marcio F Chedid; Aljamir D Chedid; Tomaz J M Grezzana Filho; Ian Leipnitz; Alexandre de Araujo; Mario R Alvares-da-Silva; Mario G Cardoni; Luciano S Guimaraes; Cleber D P Kruel; Cleber R P Kruel
Journal:  Langenbecks Arch Surg       Date:  2015-02-24       Impact factor: 3.445

2.  Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography.

Authors:  R Todd Stravitz; Ton Lisman; Velimir A Luketic; Richard K Sterling; Puneet Puri; Michael Fuchs; Ashraf Ibrahim; William M Lee; Arun J Sanyal
Journal:  J Hepatol       Date:  2011-05-19       Impact factor: 25.083

Review 3.  Management and prognosis of acute liver failure in children.

Authors:  Daniel D'Agostino; Silvia Diaz; Maria Camila Sanchez; Gustavo Boldrini
Journal:  Curr Gastroenterol Rep       Date:  2012-06

4.  Acute liver failure: a management challenge for the practicing gastroenterologist.

Authors:  Dawn McDowell Torres; Robert D Stevens; Ahmet Gurakar
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-07

5.  Role of procoagulant microparticles in mediating complications and outcome of acute liver injury/acute liver failure.

Authors:  R Todd Stravitz; Regina Bowling; Robert L Bradford; Nigel S Key; Sam Glover; Leroy R Thacker; Don A Gabriel
Journal:  Hepatology       Date:  2013-05-14       Impact factor: 17.425

6.  Effect of intravenous N-acetylcysteine infusion on haemostatic parameters in healthy subjects.

Authors:  T T Knudsen; S Thorsen; S A Jensen; K Dalhoff; L E Schmidt; U Becker; F Bendtsen
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

Review 7.  Therapeutic hypothermia for acute liver failure: toward a randomized, controlled trial in patients with advanced hepatic encephalopathy.

Authors:  R Todd Stravitz; William M Lee; Andreas H Kramer; David J Kramer; Linda Hynan; Andres T Blei
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

8.  Liver transplantation for fulminant hepatitis at Stanford University.

Authors:  Amy Lu; Humberto Monge; Kenneth Drazan; Maria Millan; Carlos O Esquivel
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

9.  Serious paracetamol poisoning and the results of liver transplantation.

Authors:  D J Mutimer; R C Ayres; J M Neuberger; M H Davies; J Holguin; J A Buckels; A D Mayer; P McMaster; E Elias
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

Review 10.  Management of acute liver failure.

Authors:  R Todd Stravitz; David J Kramer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-08-04       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.